Abalone Bio, Inc.
Biotech and Pharmaceutical
Abalone is shifting the paradigm for antibody development, isolating drug candidates directly by their modulating effects on integral membrane proteins. Our drug development programs address unmet needs in oncology, inflammation and pain. Abalone is an early stage biotech start-up in the San Francisco Bay Area. We are partnering with leading academic labs, targeting G protein-coupled receptors (GPCRs) and ion channels.